272 matching use cases
OMB 2025 Individually Reported AI Use Cases ×Health and Medical ×
OMB-IND-ROW720OMB Individually Reported

Vaccine Tracking System (VTrckS) Conversational AI Pilot

The VTrckS Conversational AI module will provide a user-friendly prompt driven approach to gaining insights into the VTrckS datasets. Current approach involves utilizing the SAP H…

OMB Individually ReportedHealth and MedicalLow risk
OMB-IND-ROW731OMB Individually Reported

FERRET

High throughput processing of unstructured data necessary for mandated reporting.

OMB Individually ReportedHealth and MedicalLow risk
OMB-IND-ROW737OMB Individually Reported

Center for Forecast and Analytics (CFA) Model Studio

This tool is intended to provide streamlined infrastructure around allowing users to bring their own models or discover existing ones and evaluate them in a streamlined way. For e…

OMB Individually ReportedHealth and MedicalLow risk
OMB-IND-ROW745OMB Individually Reported

Complaint Analysis

Conduct high volume case analysis to identify root causes/trends that can be validated by SMEs and act as a workforce multiplier.

OMB Individually ReportedHealth and MedicalLow risk
OMB-IND-ROW749OMB Individually Reported

Medicare Part C/D Marketing Material Review

Expand the volume of materials reviewed while providing consistent insights into trends and issues with materials received.

OMB Individually ReportedHealth and MedicalLow risk
OMB-IND-ROW754OMB Individually Reported

Citation Analysis and Survey Assistant (CASA - Nursing Home Survey CMS 2567)

CASA enhances the efficiency and effectiveness of monitoring and reviewing nursing home surveys across the US. It enhances how the Quality, Safety, and Oversight Group (QSOG) and…

OMB Individually ReportedHealth and MedicalLow risk
OMB-IND-ROW814OMB Individually Reported

Renamed: 356H Machine Learning (ML) Facility Supply Chain Role Classification Previously: 356H ML Facility Supply Chain Role Classification

Manual classification of facility supply chain roles from FDA industry submissions (356h forms) is time-consuming and inefficient

OMB Individually ReportedHealth and MedicalLow risk
OMB-IND-ROW815OMB Individually Reported

Renamed: Risk-based FAR Review & Decision Support Previously: Field Alert Reports (FAR) Prioritization Model

Manual and subjective assessment process for Field Alert Reports (FARs) can lead to inconsistency in prioritizing and assessing reports, potentially leading to ineffective resourc…

OMB Individually ReportedHealth and MedicalLow risk
OMB-IND-ROW816OMB Individually Reported

Analytics-Driven Supplement Evaluation (ASE)

Exponential increase in post-approval chemistry, manufacturing, and controls (CMC) change submissions, with 80% being Changes Being Effected (CBE-30/0) notifications that may be s…

OMB Individually ReportedHealth and MedicalLow risk
OMB-IND-ROW817OMB Individually Reported

Renamed: FAR-based Facility Signal Detection Tool Previously: Post-market Surveillance Reports Signal Detection and Cluster Analysis.

Need for proactive detection of quality signals in post-market surveillance reports using statistical process control and topic modeling to identify potential drug quality hazards…

OMB Individually ReportedHealth and MedicalLow risk
OMB-IND-ROW818OMB Individually Reported

MedWatch Dashboard

Need to proactively identify emerging issues and clusters within MedWatch reports using advanced analytics.

OMB Individually ReportedHealth and MedicalLow risk
OMB-IND-ROW819OMB Individually Reported

Quality Surveillance Dashboard (QSD)

Need for consistent, data-driven assessment of drug manufacturing facilities and proactive detection of potential quality signals that could indicate problems with drug safety or…

OMB Individually ReportedHealth and MedicalLow risk
OMB-IND-ROW820OMB Individually Reported

Annual Report CMC

FDA receives numerous annual reports from drug manufacturers containing important manufacturing and quality information, but key details can be difficult to locate quickly within…

OMB Individually ReportedHealth and MedicalLow risk
OMB-IND-ROW821OMB Individually Reported

Renamed: Application References Previously: Application-DMF Reference

FDA receives extensive drug application submissions that contain valuable references to related applications, but these relationships aren't always captured in existing regulatory…

OMB Individually ReportedHealth and MedicalLow risk
OMB-IND-ROW822OMB Individually Reported

Renamed: Extracting DMF Facilities from unstructured documents Previously: DMF (Drug Master File) Facilities

FDA receives Drug Master File (DMF) submissions containing valuable information about manufacturing facilities, but this data exists in various document formats that require manua…

OMB Individually ReportedHealth and MedicalLow risk
OMB-IND-ROW823OMB Individually Reported

Renamed: Information Visualization Platform (InfoViP) to Support Analysis of FAERS safety reports Previously: Information Visualization Platform (InfoViP) to Support Analysis of adverse event reports

The AI is intended to support the analysis of FAERS Individual Case Study Reports in post-market safety surveillance by automating duplicate detection, creating temporal visualiza…

OMB Individually ReportedHealth and MedicalLow risk
OMB-IND-ROW824OMB Individually Reported

LLM-Assisted VAERS Analyses

Extraction of relevant information, tabulation of data, find patterns across adverse events reports, and generate hypotheses for further investigations.

OMB Individually ReportedHealth and MedicalLow risk
OMB-IND-ROW825OMB Individually Reported

Renamed: Module 3 Facilities Extraction Previously: Module 3 Faculties

FDA receives drug application submissions (ANDA, NDA, BLA) that contain important manufacturing facility information in Module 3 documents, but this data requires manual review to…

OMB Individually ReportedHealth and MedicalLow risk
OMB-IND-ROW826OMB Individually Reported

Packaging Materials and Suppliers

FDA needs to efficiently identify which Drug Master Files (DMFs) contain specific packaging materials and understand how these materials connect to drug applications, but this inf…

OMB Individually ReportedHealth and MedicalLow risk
OMB-IND-ROW828OMB Individually Reported

Real World Data/Evidence

FDA receives numerous submissions containing real-world data and evidence, but identifying and cataloging these studies across various submission types is time-intensive and criti…

OMB Individually ReportedHealth and MedicalLow risk
OMB-IND-ROW829OMB Individually Reported

Regulatory Starting Material

FDA needs comprehensive visibility into the upstream supply chain for drug manufacturing, particularly tracking regulatory starting materials and their suppliers across approved a…

OMB Individually ReportedHealth and MedicalLow risk
OMB-IND-ROW831OMB Individually Reported

Supply Chain Resilience Program, Office of Supply Chain Resilience (OSCR) - Foresight

Estimating potential future demand of medical devices

OMB Individually ReportedHealth and MedicalLow risk
OMB-IND-ROW832OMB Individually Reported

HIVE AI Pilot

The AI is intended to assist in solving several problems related to the review process for INDs. Specifically, it aims to address issues of inefficiency, delays in identifying de…

OMB Individually ReportedHealth and MedicalLow risk
OMB-IND-ROW833OMB Individually Reported

AI and Vaccine Labeling

The app is designed to streamline vaccine label review processes, offering several key features to simplify and improve efficiency. It includes MedDRA integration for term searche…

OMB Individually ReportedHealth and MedicalLow risk